Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway

150 mg (0.25%) injected on each side of the wound at the end of surgery before wound closure.

266 mg injected on each side of the wound at the end of surgery before wound closure.

1-2 tabs (5 mg) by mouth every 4 hours as needed for pain.

Participants complete a pill diary every day for 30 days after hospital discharge.

Participants called or emailed and asked questions about symptoms three (3) and 7 days after hospital discharge, and then 1 time every week after that for a total of 8 weeks.